000 02859nam a2200409 i 4500
988 _aSpringer_BiomedLife_2019
999 _c115774
_d115774
_x1
001 115774
003 ESmaUEC
005 20230110040237.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 190807s2019 si | s |||| 0|eng d
020 _a9789811387234
024 7 _a10.1007/978-981-13-8723-4
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQD79 .C454
_b2019 EB
100 1 _aMaithani, Mukesh
_eauthor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_9672011
245 1 0 _aDevelopment of Novel Stability Indicating Methods Using Liquid Chromatography
_cby Mukesh Maithani, Parveen Bansal.
250 _a1st ed. 2019.
264 1 _aSingapore
_bSpringer International Publishing
_c2019
300 _a1 recurso en línea (XXII, 101 páginas)
_b 36 ilustraciones, 7 ilustraciones a color
336 _aTexto
_btxt
_2rdacontent
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _aChapter 1. Introduction -- Chapter 2. Research Envisaged -- Chapter 3. Drug(s) Profile -- Chapter 4. Materials and Methods -- Chapter 5. Results and Discussion -- Chapter 6. Summary and Conclusion.-.
520 3 _aReversed-phase high-performance liquid chromatography (RP-HPLC) has become the most widely used method for pharmaceutical analysis, as it ensures accuracy, specificity and reproducibility for the quantification of drugs, while avoiding interference from any of the excipients that are normally present in pharmaceutical dosage forms. This book presents a simple methodology for developing stability-indicating methods and offers a 'how-to guide' to creating novel stability-indicating methods using liquid chromatography. It provides the detailed information needed to devise a stability-indicating method for drug substances and drug products that comply with international regulatory guidelines. As such, it is a must-read for anyone engaged in analytical and bioanalytical chemistry: professionals at reference, test, and control laboratories; students and academics at research laboratories, and scientists working for chemical, pharmaceutical, and biotechnology companies.
650 7 _2embne
_aCromatografía
_9683072
700 1 _aBansal, Parveen.
_eauthor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
776 0 8 _iPrinted edition:
_z9789811387227
776 0 8 _iPrinted edition:
_z9789811387241
776 0 8 _iPrinted edition:
_z9789811387258
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-8723-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _aSI
_cm
_dz
_feng
_ggw
_h0
_b12/2019
_eIG
_zSI